AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Lexaria Bioscience Corp. Director's Dealing 2015

Oct 7, 2015

34983_dirs_2015-10-07_c7a49f14-270e-4bbe-b92e-31aa4a60ee57.zip

Director's Dealing

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEXARIA CORP. (LXRP)
CIK: 0001348362
Period of Report: 2010-01-20

Reporting Person: BUNKA CHRISTOPHER (Director, CEO, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-10-06	Common Shares	P	10000	$0.18	Acquired	5636140	Direct
2015-10-06	Common Shares	P	2500	$0.19	Acquired	5638640	Direct
2015-10-06	Common Shares	P	8256	$0.1774	Acquired	5646896	Direct
2015-10-06	Common Shares	P	10000	$0.1778	Acquired	5656896	Direct
2015-10-06	Common Shares	P	15000	$0.1779	Acquired	5671896	Direct
2015-10-06	Common Shares	P	5000	$0.1725	Acquired	5676896	Direct
2015-10-07	Common Shares	P	1500	$0.19	Acquired	5678396	Direct
2015-10-07	Common Shares	P	5000	$0.171	Acquired	5683396	Direct
2015-10-07	Common Shares	P	2000	$0.185	Acquired	5685396	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Shares	4488958	Indirect
Common Shares	5626140	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options	$0.11	2019-12-23	Common Shares (500000)	500000	Direct
Stock Options	$0.35	2016-07-11	Common Shares (200000)	700000	Direct
Stock Options	$0.1	2018-06-18	Common Shares (225000)	925000	Direct
Warrants	$0.25	2017-05-15	Common Shares (170000)	170000	Indirect